Background Women who use or are in treatment for drug use during the perinatal period
often have complex needs and presenting comorbidity. Women who use opioids during …

Objective To provide health care providers the best evidence on opioid use and women's
health. Areas of focus include pregnancy and postpartum care. Target population The target …

Background The prevalence of opiate use among pregnant women can range from 1% to
2% to as high as 21%. Just in the United States alone, among pregnant women with hospital …

Aims Through a novel synthesis of the literature and our own clinical experience, we have
derived a set of evidence‐based recommendations for consideration as guidance in the …

Thousands of pregnant and breast-feeding women take a prescribed or over-the-counter
drug preparation daily. Few of these products have been specifically tested for safety and …

In February 2015, given high rates of use of medications by pregnant women and the
relative lack of data on safety and efficacy of many drugs utilized in pregnancy, the Eunice …

Less than 10% of medicines approved by the FDA since 1980 have provided enough
information as regards risks for birth defects associated with their use (Adam et al.(2011)[1]) …

As opioid fatalities rise in North America, the need to improve the supports available to those
who are dependent on opioids and pregnant has become more urgent. This paper …

The opioid epidemic is a public health crisis, and pregnancy-associated morbidity and
mortality due to substance use highlights the need to prioritize substance use as a major …

Most women take either prescribed or over-the-counter medication during pregnancy.
Pregnant women often make independent decisions about their treatment and require …